Table 2 Characteristics of the study subject across patients with and without breast cancer and also across the quartile categorize of the Mediterranean Dietary Quality Index (MedDQI).
| Â | Breast cancer | Quartiles of Mediterranean Dietary Quality Index | Â | |||||
|---|---|---|---|---|---|---|---|---|
Yes (n = 150) | No (n = 150) | P* | Q1 (n = 103) MedDQI score range: 3–5 | Q2 (n = 91) | Q3 (n = 49) | Q4 (n = 57) MedDQI score range:8–11 | P* | |
Age (y) | 46.6 ± 10.7 | 46.6 ± 10.7 | < 0.001 | 47.0 ± 10.5 | 47.1 ± 10.0 | 44.5 ± 10.5 | 46.6 ± 12.3 | 0.4 |
BMI (kg/m2) | 28.1 ± 4.6 | 28.2 ± 5.2 | 0.8 | 28.70 ± 5.32 | 28.73 ± 4.66 | 27.84 ± 4.25 | 26.65 ± 4.97 | 0.01 |
Physical activity (Met/min/week) | 475.8 ± 1043.2 | 590.0 ± 843.8 | 0.2 | 644.4 ± 970.2 | 406.8 ± 708 | 388.8 ± 561 | 655.8 ± 1389.6 | 0.8 |
Family history of breast cancer yes, (%) | 30 (20) | 39 (26) | 0.2 | 21 (20.4) | 20 (22) | 12 (24.5) | 16 (28) | 0.8 |
University graduated n, (%) | 21 (14) | 28 (18.7) | 0.6 | 19 (18.5) | 13 (14.3) | 8 (16.3) | 9 (15.9) | 0.3 |
Urban-resided n, (%) | 140 (93.3) | 139 (92.7) | 0.8 | 99 (96.1) | 85 (93.4) | 46 (93.9) | 49 (86) | 0.1 |
Married, n (%) | 129 (86) | 136 (90.7) | 0.2 | 86 (83.5) | 83 (91.2) | 46 (93.9) | 50 (87.7) | 0.5 |
Menopause status yes, n (%) | 62 (41.3) | 54 (36) | 0.3 | 41 (39.8) | 37 (40.7) | 15 (30.6) | 23 (40.4) | 0.6 |
Age at first menarche (year) | 14.4 ± 1.7 | 13.4 ± 1.6 | 0.2 | 14.7 (1.7) | 13.6 (1.2) | 13.2 (1.5) | 13.6 (1.7) | 0.2 |
Number of child, n | 2.6 ± 2.1 | 2.4 ± 2.1 | 0.3 | 2.5 (1.9) | 2.5 (2.4) | 2.3 (1.6) | 2.6 (2.3) | 0.9 |
Length of breastfeeding (year) | 4.2 ± 3.5 | 3.5 ± 2.7 | 0.059 | 4.07 (3.3) | 3.8 (2.8) | 3.3 (3.1) | 4.2 (3.2) | 0.8 |
History of HRT, n (%) | 12 (8) | 8 (5.3) | 0.3 | 6 (5.8) | 2 (2.2) | 6 (12.2) | 2 (10.5) | 0.07 |
Smoking, never smoked, n (%) | 147 (98) | 144 (96) | 0.3 | 101 (98.1) | 87 (95.6) | 47 (95.9) | 56 (98.2) | 0.7 |
Alcohol, never used, n (%) | 149 (99) | 148 (98) | 0.5 | 102 (99) | 90 (98.9) | 48 (98) | 57 (100) | 0.5 |
Dietary supplement use, yes, n (%) | 80 (53.3) | 84 (56) | 0.09 | 61 (59.2) | 49 (53.8) | 24 (49) | 30 (52.6) | 0.6 |
Medication use §,yes, n (%) | 64 (42) | 62 (41) | 0.8 | 45 (43.7) | 37 (40.7) | 18 (36.7) | 26 (45.6) | 0.3 |
Comorbidities †, n (%) | 38 (25) | 31 (20) | 0.3 | 46 (44.7) | 42 (46.2) | 26 (53.1) | 29 (50.9) | 0.3 |